Companion diagnostics (CDx) are medical devices, most commonly an in vitro diagnostic (IVD) that provides information necessary for the safe and effective use of a corresponding drug or biological product. CDx support the expansion of personalized medicine by assessing predictive biomarkers, such as genetic variation or protein expression, in individual patients to determine the most effective use of an associated therapy.
Scope
- Oncology is still the most common use for companion diagnostics, as they play a crucial role in the development of targeted therapies
- Companion diagnostics can be used to identify patients who are likely to benefit from a particular therapy
- There is potential for companion diagnostics to be applied in other therapy areas, such as rare diseases, neurological disorders and cardiovascular diseases.
Reasons to Buy
- Understand how companion diagnostics are evolving, the current uses and future potential.
- Understand the key players, the challengers, and product offerings.
- Understand key applications of companion diagnostics.
Table of Contents
- Executive Summary
- Players
- Technology Briefing
- Trends
- Industry Analysis
- Value Chain
- Companies
- Sector Scorecard
- Glossary
- Further Reading
- Thematic Research Methodology
- About the Analyst
- Contact the Publisher
